Dexa Group Wins Second Primaduta Award, Strengthening Global Presence of Indonesian Healthcare Products
SOUTH TANGERANG - Dexa Group has once again been honored with the Primaduta Award by the Ministry of Trade of the Republic of Indonesia. The 2026 award was presented to Glorious Dexa Mandaya Philippines, Dexa Medica’s entity in the Philippines, under the Export Supporting Diaspora category for its key role in marketing Indonesian healthcare products in the country. This marks the second Primaduta Award for Dexa Group, following an earlier win by Dynamic Argon Co., Ltd. in Cambodia in 2024.
The award was presented by Minister of Trade Budi Santoso to Setiadi Wono, Country Manager for the Philippines, during the Trade Expo Indonesia (TEI) Night gala at ICE BSD on Wednesday, October 14, 2026.
The ceremony was attended by Dexa Group Commissioner Gracianti Soetikno, members of the Dexa International Business team, and the Deputy Chief of Mission of the Indonesian Embassy (KBRI) in Manila, Victorina Hesti Dewayani, alongside the KBRI Manila delegation.
The Primaduta Award is an official recognition presented by the Indonesian Government through the Ministry of Trade to foreign trading partners—including importers, buyers, diaspora businesses, and Indonesian overseas missions—for their outstanding contributions to promoting and growing trade for Indonesian products.
Minister of Trade Budi Santoso highlighted the ministry’s three core focus areas: safeguarding the domestic market, expanding export market footprint, and driving the "Local to Global" initiative.
"Expanding export markets is a key strategic effort to open access across various countries through trade agreements. These initiatives are expected to unlock greater opportunities for Indonesian products to enter international markets and enhance their global competitiveness," stated Minister Budi Santoso.
Dexa Medica first began exporting products to the Philippines in 2004 and established a local operational office in 2013. In the Philippines, Dexa Group markets branded generic pharmaceuticals and products derived from Indonesia's biodiversity research, including its Integrative Natural Modern Medicine portfolio (Obat Modern Alami Integratif or OMAI). Marketed products include Stimuno, Disolf, Anerdic, Inbumin, and Inlacin.
To support scientific awareness and clinical credibility, Dexa Medica consistently hosts symposia featuring medical experts from Indonesia and the Philippines to present research findings and clinical trials on OMAI products.
Setiadi Wono, Country Manager for the Philippines, expressed that the award represents recognition of the team's dedication to building strong business relationships in the Philippines and expanding commercial opportunities for Indonesian products.
"This award motivates us to continue strengthening our partnerships in the Philippines and opening broader pathways for Indonesian products. As part of Dexa Group, we strive to build long-term trust with our business partners by deeply understanding market needs. We hope these ongoing efforts will continue to drive positive business growth while helping Indonesian products expand globally," said Mr. Setiadi.
President Director of PT Dexa Medica, V. Hery Susanto, emphasized that international business growth is integral to the company’s commitment to elevating the Indonesian healthcare industry on the global stage.
"As an Indonesian healthcare company expanding internationally, Dexa Medica builds trust through product quality, technical capabilities, and enduring partnerships. Dexa Group’s presence across four continents not only broadens our commercial reach, but also strengthens global confidence in Indonesian products," Mr. Hery stated.
Dexa Group Commissioner Gracianti Soetikno praised the team's efforts in cultivating and maintaining strong stakeholder relationships in the Philippines.
"Dexa Group’s international journey is built on continuous efforts to cultivate trust and collaboration. This award acknowledges our team's hard work in fortifying business ties in the Philippines. We hope the synergies established will keep growing, creating added value for our partners while reinforcing the presence of Indonesian products worldwide," said Ms. Gracianti.
Previously, Dynamic Argon Co., Ltd. in Cambodia received the 2024 Primaduta Award in the Indonesian Product Promoter category. The awards in 2024 and 2026 highlight the substantial contributions of Dexa Group’s international entities in driving trade and promotion for Indonesian products abroad.
Dexa Group also holds a strong track record with Primaniyarta—the Indonesian Government's top award for outstanding exporters—having won it five times (in 2005, 2017, 2018, 2019, and 2021) through PT Dexa Medica and PT Ferron Par Pharmaceuticals. Key products contributing to this export expansion include Stimuno, Boska, and Glucient SR.
The 2026 Primaduta Award marks another milestone in Dexa Group’s mission to extend the reach of Indonesian healthcare products through technical excellence, scientific collaboration, and long-term business partnerships, aligning with its vision to be a Respected International Healthcare Company.